Fundraising Fox
🦊/Companies
Sign in

Telesis Bio

San Diego, US · Founded 2013 · Delaware corporation · 42 employees on LinkedIn · 2 known investors

Find your way into Telesis Bio

302 people in our graph share verified history with the Telesis Bio team — schools, employers, funds. One of them is your warm intro.

Erica Bresciaunlockedknows Daniel G. Gibson · together at University of Southern California (overlapped)
×5knows the team · via University at Buffalo
×5knows the team · via University of Southern California
knows the team · via J. Craig Venter Institute

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

AI & Machine LearningBiotechDeep TechHardwareHealthtech

Founders & leadership

Telesis Bio was founded in 2013 by Daniel G. Gibson and Todd R. Nelson.

DGDaniel G. Gibson
Daniel G. GibsoninCo-founder · Chief Technology OfficerDaniel G. Gibson holds a Ph.D. from the University of Southern California and an undergraduate degree from SUNY Buffalo. He co-founded Telesis Bio in 2012 and serves as Chief Technology Officer, developing DNA synthesis technologies; earlier, he led synthetic biology research at the J. Craig Venter Institute and Synthetic Genomics, including work on synthetic genomes and cells.
TRTodd R. Nelson
Todd R. NelsonCo-founder
EEEric Esser
Eric EsserinPresident and CEO at Telesis Bio
WF
William F. SniderNamed on SEC filing
ALAndrea L. Jackson
Andrea L. JacksoninNamed on SEC filingPartner at Northpond Ventures
CA
Christine A. TsingosNamed on SEC filing
RH
Robert H. CutlerNamed on SEC filing
AV
Annette V. TumoloNamed on SEC filing
JN
Jami NachtsheimNamed on SEC filing

Board

PMPaul Meister
Paul MeisterBoard directorPartner at Novalis LifeSciences
FR
Franklin R. WitneyChair of the Board of Directors

Investors · 2

Novalis LifeSciencesPortsmouth
Northpond Venturesreported · 2 sourcesBethesda · $100K – $5M

Funding

SEC filings, press & company announcements

$49M disclosed across 2 rounds · 2023–2025

▶$28MraisedJun 2023 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Franklin R. WitneyDirector
  • Eric EsserExecutive Officer
  • Paul MeisterDirector
  • William F. SniderDirector
  • Andrea L. JacksonDirector
  • Christine A. TsingosDirector
  • Robert H. CutlerExecutive Officer
  • Annette V. TumoloDirector
  • Jami NachtsheimDirector
  • Daniel G. GibsonExecutive Officer
  • Todd R. NelsonExecutive Officer, Director
Offering amount
$74.2M
Amount sold
$28M
Sales commissions
$850K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Twist Bioscience30 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

Companies competing with Telesis Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Telesis Bio Stock Price | TBIO Stock Quote, News, and History | Markets Insidermarkets.businessinsider.com · Aug 2026Telesis Bio to Raise up to $21M Through Private Stock Placement | GenomeWebgenomeweb.com · Mar 2025Telesis Bio Raises $21M to Scale Revolutionary DNA Synthesis Platform | TBIO Stock Newsstocktitan.net · Mar 2025Telesis Bio Secures Financing of $28.0 Millionglobenewswire.com

Frequently asked questions

What does Telesis Bio do?
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.
Who founded Telesis Bio?
Telesis Bio was founded by Daniel G. Gibson, Todd R. Nelson in 2013.
Who are Telesis Bio's investors?
Telesis Bio's investors include Novalis LifeSciences, Northpond Ventures.
How much funding has Telesis Bio raised?
Telesis Bio has disclosed $49M raised across 2 rounds.
Where is Telesis Bio headquartered?
Telesis Bio is headquartered in San Diego, US.